Pfizer

A study that included 1.2 million people in Israel, half of which were fully vaccinated with the Pfizer/BioNTech drug, shows the vaccine is highly effective at preventing severe COVID-19. The researchers also learned that the vaccine offers excellent protection against severe COVID-19, hospitalization, and death — even after just one dose. The study was conducted …

Pfizer and BioNTech announced a significant change to their coronavirus vaccine that could have a dramatic impact on shipping logistics and vaccine availability. The two companies say the drug can be stored at higher temperatures, which makes it easier to transport and should extend the vaccine’s reach. Pfizer and BioNTech say the vaccine can be …

A study from Israel indicates that people who received the Pfizer/BioNTech coronavirus vaccine develop an immune response significantly stronger than COVID-19 survivors. These researchers think this sort of immunity might completely prevent COVID-19 transmission, although more data is needed to prove that’s the case. The goal of current COVID-19 vaccines is to prevent severe illness …

Pfizer and BioNTech announced they completed testing that shows the key mutation present on the UK and South African coronavirus strains would not create resistance to the vaccine. Researchers tested sera containing antibodies from 20 volunteers who received the vaccine during the Phase 3 trial and found that the coronavirus-specific proteins neutralized the key mutation. …

The Pfizer coronavirus vaccine is even more effective than experts had hoped, according to interim data released earlier this week. Figures may change, but Pfizer seems to be on track to be the first vaccine maker to get FDA authorization for a drug that can reduce the spread of COVID-19. There is one problem with …